{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:24:37Z","timestamp":1789773877685,"version":"4.0.1"},"reference-count":231,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF-220384"],"award-info":[{"award-number":["IF-220384"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.arr.2024.102639","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:44:39Z","timestamp":1734345879000},"page":"102639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Targeting tau in Alzheimer\u2019s and beyond: Insights into pathology and therapeutic strategies"],"prefix":"10.1016","volume":"104","author":[{"given":"Sunidhi","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-7970","authenticated-orcid":false,"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102639_bib1","doi-asserted-by":"crossref","first-page":"30335","DOI":"10.1074\/jbc.M002590200","article-title":"Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament-like conformation","volume":"275","author":"Ackmann","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570223","article-title":"Chronic sodium selenate treatment restores deficits in cognition and synaptic plasticity in a murine model of tauopathy","volume":"13","author":"Ahmed","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awz100","article-title":"Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody","volume":"142","author":"Albert","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102639_bib4","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/jcm10204687","article-title":"Aging with down syndrome\u2014where are we now and where are we going?","volume":"10","author":"Alldred","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2024.102639_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41467-017-00480-0","article-title":"Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau","volume":"8","author":"Ambadipudi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102639_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-017-0022-z","article-title":"Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo","volume":"21","author":"Apicco","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-003-0671-8","article-title":"Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer\u2019s disease, Pick\u2019s disease, progressive supranuclear palsy and corticobasal degeneration","volume":"105","author":"Arai","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s10571-020-01027-6","article-title":"Role of Microgliosis and NLRP3 Inflammasome in Parkinson\u2019s Disease Pathogenesis and Therapy","volume":"42","author":"de Ara\u00fajo","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102639_bib10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1212\/WNL.54.9.1787","article-title":"Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene","volume":"54","author":"Arima","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102639_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0006-8993(89)91396-6","article-title":"Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer\u2019s disease","volume":"477","author":"Bancher","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102639_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense oligonucleotide therapies for Neurodegenerative diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/brain\/awaa033","article-title":"Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum","volume":"143","author":"Bevan-Jones","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102639_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bpa.12757","article-title":"Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study","volume":"30","author":"Bieniek","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2024.102639_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s004010051077","article-title":"Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease","volume":"98","author":"Botez","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib17","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1074\/jbc.AC119.009198","article-title":"Liquid-liquid phase separation of tau protein: the crucial role of electrostatic interactions","volume":"294","author":"Boyko","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol. (Berl. )"},{"key":"10.1016\/j.arr.2024.102639_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0304-3940(87)90204-7","article-title":"Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes","volume":"76","author":"Braak","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102639_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0304-3940(86)90288-0","article-title":"Occurrence of neuropil threads in the senile human brain and in Alzheimer\u2019s disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques","volume":"65","author":"Braak","year":"1986","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102639_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2990.1989.tb01146.x","article-title":"Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia","volume":"15","author":"Braak","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102639_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nphys3532","article-title":"Polymer physics of intracellular phase transitions","volume":"11","author":"Brangwynne","year":"2015","journal-title":"Nat. Phys."},{"key":"10.1016\/j.arr.2024.102639_bib24","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.cell.2024.03.015","article-title":"Human iPSC 4R tauopathy model uncovers modifiers of tau propagation","volume":"187","author":"Bravo","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102639_bib25","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1523\/JNEUROSCI.3059-10.2010","article-title":"Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy","volume":"30","author":"Brunden","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ene.15603","article-title":"The many faces of globular glial tauopathy: a clinical and imaging study","volume":"30","author":"Buciuc","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib27","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/antiox11122402","article-title":"Therapeutics of Alzheimer\u2019s disease: recent developments","volume":"11","author":"Burns","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2024.102639_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12024-023-00624-3","article-title":"Chronic traumatic encephalopathy (CTE)\u2014features and forensic considerations","volume":"19","author":"Byard","year":"2023","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.arr.2024.102639_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","article-title":"Rapamycin and Alzheimer disease: a double-edged sword?","volume":"15","author":"Carosi","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2024.102639_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/genes11060667","article-title":"Development of novel chemically-modified nucleic acid molecules for efficient inhibition of human MAPT gene expression","volume":"11","author":"Chakravarthy","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.arr.2024.102639_bib31","article-title":"Atypical neurological manifestations in anti-IgLON5 disease: a case report","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0040-1713620","article-title":"Repetitive head trauma induces chronic traumatic encephalopathy by multiple mechanisms","volume":"40","author":"Cherry","year":"2020","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib33","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1007\/s00415-020-09927-9","article-title":"Pick\u2019s disease: clinicopathologic characterization of 21 cases","volume":"267","author":"Choudhury","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40478-019-0691-9","article-title":"Tau exhibits unique seeding properties in globular glial tauopathy","volume":"7","author":"Chung","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102639_bib35","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.2147\/JIR.S280953","article-title":"Interferon-driven immune dysregulation in down syndrome: a review of the evidence","volume":"14","author":"Chung","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.arr.2024.102639_bib36","first-page":"2","article-title":"Neurotrophic peptides: potential drugs for treatment of amyotrophic lateral sclerosis and Alzheimer\u2019s disease","volume":"3","author":"Ciesler","year":"2013","journal-title":"Open J. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.121","article-title":"An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity","volume":"3","author":"Cisbani","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2024.102639_bib38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2024.102639_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","article-title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","volume":"139","author":"Colin","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.biochem.74.082803.133400","article-title":"The biochemistry of Parkinson\u2019s disease","volume":"74","author":"Cookson","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102639_bib41","doi-asserted-by":"crossref","first-page":"15383","DOI":"10.3390\/ijms232315383","article-title":"Tau isoforms: gaining insight into MAPT alternative splicing","volume":"23","author":"Corsi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib42","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102639_bib43","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.96.10.5598","article-title":"Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements","volume":"96","author":"D\u2019Souza","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib44","doi-asserted-by":"crossref","first-page":"17700","DOI":"10.1074\/jbc.M909470199","article-title":"Determinants of 4-repeat tau expression: coordination between enhancing and inhibitory splicing sequences for exon 10 Inclusion*","volume":"275","author":"D\u2019Souza","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: a neuropathological study of 15 elderly Huntington\u2019s disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s004010051052","article-title":"A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy","volume":"98","author":"Delisle","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2024.102639_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13195-020-00743-x","article-title":"The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice","volume":"13","author":"Di","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","article-title":"Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice","volume":"6","author":"Duan","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.arr.2024.102639_bib51","first-page":"2820","article-title":"Alpha-synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson\u2019s disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.arr.2024.102639_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","article-title":"Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease","volume":"74","author":"Edwards","year":"2010","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12896","article-title":"The role of innate immunity in Alzheimer\u2019s disease","volume":"297","author":"Ennerfelt","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.arr.2024.102639_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/15548627.2019.1633862","article-title":"MAPT\/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration","volume":"16","author":"Feng","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2024.102639_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fern\u00e1ndez-Nogales","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102639_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00401-002-0600-2","article-title":"Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains","volume":"104","author":"Ferrer","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1750-3639.2003.tb00007.x","article-title":"Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease","volume":"13","author":"Ferrer","year":"2003","journal-title":"Brain Pathol. Zur. Switz."},{"key":"10.1016\/j.arr.2024.102639_bib59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib60","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.410410606","article-title":"Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference","volume":"41","author":"Foster","year":"1997","journal-title":"Conf. Particip. Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2004.07.016","article-title":"Tau phosphorylation increases in symptomatic mice overexpressing A30P \u03b1-synuclein","volume":"192","author":"Frasier","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib62","series-title":"in: Movement Disorders Phenomenology","first-page":"135","article-title":"Progressive Supranuclear Palsy (PSP)","author":"Frucht","year":"2024"},{"key":"10.1016\/j.arr.2024.102639_bib63","article-title":"Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations","volume":"7","author":"G","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.599384","article-title":"Tauopathy and Movement Disorders\u2014Unveiling the Chameleons and Mimics","volume":"11","author":"Ganguly","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094259","article-title":"Extracellular \u03b1-synuclein leads to microtubule destabilization via GSK-3\u03b2-dependent Tau phosphorylation in PC12 cells","volume":"9","author":"G\u0105ssowska","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102639_bib66","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.arr.2024.102639_bib67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102639_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102639_bib70","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1873-3468.13108","article-title":"Tau filaments in neurodegenerative diseases","volume":"592","author":"Goedert","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib72","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0014-5793(99)00508-6","article-title":"Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments","volume":"450","author":"Goedert","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib73","series-title":"in: Chronic Traumatic Encephalopathy (CTE), SpringerBriefs in Psychology","first-page":"11","article-title":"Clinical Manifestations of CTE: Disruptions in Cognition, Mood, & Behavior","author":"Golden","year":"2019"},{"issue":"23","key":"10.1016\/j.arr.2024.102639_bib74","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Current medicinal chemistry"},{"key":"10.1016\/j.arr.2024.102639_bib75","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.3390\/ijms23084192","article-title":"Alzheimer\u2019s disease and tau self-assembly: in the search of the missing link","volume":"23","author":"Gonz\u00e1lez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib76","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ymthe.2020.10.007","article-title":"Anti-tau scFvs targeted to the cytoplasm or secretory pathway variably modify pathology and neurodegenerative phenotypes","volume":"29","author":"Goodwin","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib77","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington\u2019s disease a tauopathy?","volume":"139","author":"Gratuze","year":"2016","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib78","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1531-8249(200012)48:6<939::AID-ANA17>3.0.CO;2-1","article-title":"A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies","volume":"48","author":"Grazia Spillantini","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102639_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102639_bib81","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(98)01696-2","article-title":"FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10","volume":"443","author":"Hasegawa","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib84","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.celrep.2017.08.042","article-title":"Local nucleation of microtubule bundles through tubulin concentration into a condensed tau phase","volume":"20","author":"Hern\u00e1ndez-Vega","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102639_bib85","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/neup.12668","article-title":"Globular glial tauopathy Type I presenting with behavioral variant frontotemporal dementia","volume":"40","author":"Hirano","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.arr.2024.102639_bib86","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington\u2019s disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2024.102639_bib87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","article-title":"Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial","volume":"20","author":"H\u00f6glinger","year":"2021","journal-title":"Lancet Neurol."},{"issue":"174","key":"10.1016\/j.arr.2024.102639_bib88","first-page":"664","article-title":"New classification of tauopathies","volume":"2018","author":"H\u00f6glinger","year":"2018","journal-title":"Rev. Neurol. Int. SFN SOFMA Meet."},{"key":"10.1016\/j.arr.2024.102639_bib89","first-page":"271","article-title":"Interaction between \u03b1-synuclein and tau genotypes and the progression of Parkinson\u2019s disease","volume":"1","author":"Huang","year":"2011","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib90","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib91","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/alz.12453","article-title":"A critical appraisal of tau-targeting therapies for primary and secondary tauopathies","volume":"18","author":"Imbimbo","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102639_bib92","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/alz.12453","article-title":"A critical appraisal of tau-targeting therapies for primary and secondary tauopathies","volume":"18","author":"Imbimbo","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102639_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102342","article-title":"Navigating the Maze of Alzheimer\u2019s disease by exploring BACE1: Discovery, current scenario, and future prospects","volume":"98","author":"Iram","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102639_bib94","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of tau and alpha-synuclein epitopes in Lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib96","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib97","doi-asserted-by":"crossref","first-page":"15997","DOI":"10.1073\/pnas.0808084105","article-title":"Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia","volume":"105","author":"Ittner","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib98","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41591-021-01465-9","article-title":"Tau-targeting antibody therapies: too late, wrong epitope or wrong target?","volume":"27","author":"Jabbari","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102639_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1750-3639.1998.tb00161.x","article-title":"Dementia with grains (argyrophilic grain disease)","volume":"8","author":"Jellinger","year":"1998","journal-title":"Brain Pathol. Zur. Switz."},{"key":"10.1016\/j.arr.2024.102639_bib100","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"\u03b1-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356*","volume":"274","author":"Jensen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib101","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1128\/MCB.20.11.4036-4048.2000","article-title":"Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17","volume":"20","author":"Jiang","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.arr.2024.102639_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104636","article-title":"Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology","volume":"134","author":"Joly-Amado","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib103","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0014-5793(96)01386-5","article-title":"RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments","volume":"399","author":"Kampers","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib104","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1038\/s41467-020-16580-3","article-title":"Liquid-liquid phase separation induces pathogenic tau conformations in vitro","volume":"11","author":"Kanaan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102639_bib105","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s12035-022-03164-z","article-title":"Role of tau in various tauopathies, treatment approaches, and emerging role of nanotechnology in neurodegenerative disorders","volume":"60","author":"Kaur","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib106","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1083\/jcb.151.6.1257","article-title":"Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules","volume":"151","author":"Kedersha","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2024.102639_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101924","article-title":"Nature\u2019s toolbox against tau aggregation: An updated review of current research","volume":"87","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102639_bib108","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00401-021-02318-y","article-title":"Tau immunotherapy is associated with glial responses in FTLD-tau","volume":"142","author":"Kim","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib109","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/neup.12708","article-title":"Multiple system aging-related tau astrogliopathy with complex proteinopathy in an oligosymptomatic octogenarian","volume":"41","author":"Klotz","year":"2021","journal-title":"Neuropathol. Off. J. Jpn. Soc. Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-981-32-9358-8_24","article-title":"Tau Condensates","volume":"1184","author":"Kosik","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.arr.2024.102639_bib111","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2004.01.007","article-title":"Fibrillization of \u03b1-synuclein and tau in familial Parkinson\u2019s disease caused by the A53T \u03b1-synuclein mutation","volume":"187","author":"Kotzbauer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib112","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12031-016-0829-1","article-title":"Interactions between \u03b1-synuclein and tau protein: implications to neurodegenerative disorders","volume":"60","author":"Li","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib113","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet. TIG"},{"key":"10.1016\/j.arr.2024.102639_bib114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-021-00240-7","article-title":"Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies","volume":"10","author":"Li","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102639_bib115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/JAD-190635","article-title":"Ubiquitin specific protease 13 regulates tau accumulation and clearance in models of Alzheimer\u2019s disease.","volume":"72","author":"Liu","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102639_bib116","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41422-024-00957-w","article-title":"APOE3ch alleviates A\u03b2 and tau pathology and neurodegeneration in the human APPNL-G-F cerebral organoid model of Alzheimer\u2019s disease","volume":"34","author":"Liu","year":"2024","journal-title":"Cell Res."},{"issue":"7993","key":"10.1016\/j.arr.2024.102639_bib117","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-023-06788-w","article-title":"Disease-specific tau filaments assemble via polymorphic intermediates","volume":"625","author":"L\u00f6vestam","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib118","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.RA119.012284","article-title":"Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation","volume":"295","author":"Lu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852215","article-title":"Anti-IgLON5 disease - the current state of knowledge and further perspectives","volume":"13","author":"Madetko","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102639_bib120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/ana.25911","article-title":"Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy","volume":"88","author":"Malpetti","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib121","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102639_bib122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: Involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102639_bib123","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer\u2019s disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib124","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib125","series-title":"in: Handbook of Clinical Neurology","first-page":"297","article-title":"The neuropathology of chronic traumatic encephalopathy","author":"Mckee","year":"2018"},{"key":"10.1016\/j.arr.2024.102639_bib126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5414\/NP301243","article-title":"History of Pick\u2019s disease","volume":"39","author":"Mikol","year":"2020","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib127","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102639_bib128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-003-0742-x","article-title":"Argyrophilic grain disease: molecular genetic difference to other four-repeat tauopathies","volume":"106","author":"Miserez","year":"2003","journal-title":"Acta Neuropathol. (Berl. )"},{"key":"10.1016\/j.arr.2024.102639_bib129","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0301-0082(99)00019-2","article-title":"The selective vulnerability of striatopallidal neurons","volume":"59","author":"Mitchell","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroscience.2008.01.030","article-title":"Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer\u2019s disease, and in Parkinson\u2019s disease and related alpha-synucleinopathies","volume":"152","author":"Muntan\u00e9","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102639_bib131","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00005072-199912000-00002","article-title":"Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits","volume":"58","author":"Murrell","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib132","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(99)00294-X","article-title":"Accelerated filament formation from tau protein with specific FTDP-17 missense mutations","volume":"447","author":"Nacharaju","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib133","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11011-020-00591-6","article-title":"Recent advances in tau-directed immunotherapy against Alzheimer\u2019s disease: an overview of pre-clinical and clinical development","volume":"35","author":"Ng","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2024.102639_bib134","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1091\/mbc.E14-06-1049","article-title":"Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing","volume":"26","author":"Niederst","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.arr.2024.102639_bib135","article-title":"Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein","volume":"1867","author":"Nieznanska","year":"2021","journal-title":"Biochim. Biophys. Acta BBA\u00a0Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102639_bib136","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00798","article-title":"Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead","volume":"12","author":"Novak","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","article-title":"ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer\u2019s disease","volume":"1","author":"Novak","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2024.102639_bib139","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acs.jmedchem.0c01605","article-title":"Evaluation of structure-activity relationship of microtubule (MT)-targeting 1,2,4-triazolo[1,5-a]pyrimidines identifies new candidates for neurodegenerative tauopathies","volume":"64","author":"Oukoloff","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2024.102639_bib140","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib141","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","article-title":"Tau in the pathophysiology of Parkinson\u2019s disease","volume":"71","author":"Pan","year":"2021","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.arr.2024.102639_bib142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/07317115.2019.1694115","article-title":"The progressive supranuclear palsy: past and present aspects","volume":"43","author":"Parthimos","year":"2020","journal-title":"Clin. Gerontol."},{"key":"10.1016\/j.arr.2024.102639_bib143","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102639_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47033-7","article-title":"USP10 is a critical factor for Tau-positive stress granule formation in neuronal cells","volume":"9","author":"Piatnitskaia","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102639_bib145","first-page":"1141","article-title":"Tau protein in neurodegenerative diseases - a review","volume":"58","author":"P\u00eer\u015fcoveanu","year":"2017","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"10.1016\/j.arr.2024.102639_bib146","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/jmg.2005.031377","article-title":"Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration","volume":"42","author":"Pittman","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib147","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib148","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s004010050565","article-title":"Pick\u2019s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment","volume":"92","author":"Probst","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102476","article-title":"Recent advancement in understanding of Alzheimer\u2019s disease: Risk factors, subtypes, and drug targets and potential therapeutics","author":"Prabha","year":"2024","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/j.arr.2024.102639_bib150","first-page":"155","article-title":"Argyrophilic grain disease (AgD), a frequent and largely underestimated cause of dementia in old patients","volume":"158","author":"Probst","year":"2002","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib151","series-title":"in: Translational Research in Biomedical Sciences: Recent Progress and Future Prospects","first-page":"227","article-title":"Huntington\u2019s Disease: A Neurodegenerative Disorder","author":"R","year":"2024"},{"key":"10.1016\/j.arr.2024.102639_bib152","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib153","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib154","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/nmt-2021-0022","article-title":"NM101 Phase III study of NE3107 in Alzheimer\u2019s disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance","volume":"11","author":"Reading","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.arr.2024.102639_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.572850","article-title":"Astrocytes in tauopathies","volume":"11","author":"Reid","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib156","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnen\/59.11.990","article-title":"Tau Gene Mutation K257T causes a tauopathy similar to Pick\u2019s disease","volume":"59","author":"Rizzini","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib157","doi-asserted-by":"crossref","first-page":"502","DOI":"10.34172\/apb.2023.061","article-title":"Tau protein biosensors in the diagnosis of Neurodegenerative diseases","volume":"13","author":"Sadeghzadeh","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.arr.2024.102639_bib158","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jnen\/61.9.789","article-title":"Severe involvement of ambient gyrus in dementia with grains","volume":"61","author":"Saito","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib159","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12640-018-9974-3","article-title":"siRNA blocking of mammalian target of rapamycin (mTOR) attenuates pathology in annonacin-induced tauopathy in mice","volume":"35","author":"Salama","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2024.102639_bib160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JHD-220557","article-title":"Untangling the role of tau in Huntington\u2019s disease pathology","volume":"12","author":"Salem","year":"2023","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00327","article-title":"The MAPT H1 haplotype is a risk factor for Alzheimer\u2019s disease in APOE \u03b54 non-carriers","volume":"11","author":"S\u00e1nchez-Juan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib162","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102639_bib163","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2024.102639_bib164","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuron.2016.04.042","article-title":"Increased 4R-tau induces pathological changes in a human-tau mouse model","volume":"90","author":"Schoch","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102639_bib165","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0014-5793(97)00859-4","article-title":"Different distribution of phosphorylated tau protein isoforms in Alzheimer\u2019s and Pick\u2019s diseases","volume":"412","author":"Sergeant","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib166","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archneurol.2011.17","article-title":"Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes","volume":"68","author":"Set\u00f3-Salvia","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib167","doi-asserted-by":"crossref","unstructured":"Shiells, H., Schelter, B.O., Bentham, P., Baddeley, T.C., Rubino, C.M., Ganesan, H., Hammel, J., Vuksanovic, V., Staff, R.T., Murray, A.D., Bracoud, L., Wischik, D.J., Riedel, G., Gauthier, S., Jia, J., Moebius, H.J., Hardlund, J., Kipps, C.M., Kook, K., Storey, J.M.D., Harrington, C.R., Wischik, C.M., n.d. Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia. J. Alzheimers Dis. 75, 501\u2013519. https:\/\/doi.org\/10.3233\/JAD-191173.","DOI":"10.3233\/JAD-191173"},{"key":"10.1016\/j.arr.2024.102639_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101782","article-title":"Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy","volume":"187","author":"Shin","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib169","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2009.02.011","article-title":"NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model","volume":"34","author":"Shiryaev","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib170","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1038\/s41467-020-16984-1","article-title":"Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons","volume":"11","author":"Silva","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102639_bib171","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib172","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of \u03b1-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13554794.2012.732087","article-title":"Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?","volume":"20","author":"Sitek","year":"2014","journal-title":"Neurocase"},{"key":"10.1016\/j.arr.2024.102639_bib174","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/424492","article-title":"Linkage disequilibrium and association of MAPT H1 in Parkinson disease","volume":"75","author":"Skipper","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib175","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3233\/JAD-181001","article-title":"Methylene blue inhibits formation of tau fibrils but not of granular tau oligomers: a plausible key to understanding failure of a clinical trial for Alzheimer\u2019s disease","volume":"68","author":"Soeda","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102639_bib176","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1750-3639.1998.tb00162.x","article-title":"Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies","volume":"8","author":"Spillantini","year":"1998","journal-title":"Brain Pathol. Zur. Switz."},{"key":"10.1016\/j.arr.2024.102639_bib177","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2006-9S342","article-title":"Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD)","volume":"9","author":"Spillantini","year":"2006","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.arr.2024.102639_bib178","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3\u2013ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"Pt 5","key":"10.1016\/j.arr.2024.102639_bib179","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/brain\/123.5.880","article-title":"Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations","volume":"123","author":"Stanford","year":"2000","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-019-0477-0","article-title":"Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer\u2019s disease","volume":"11","author":"Startin","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib181","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1508","article-title":"A common inversion under selection in Europeans","volume":"37","author":"Stefansson","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2024.102639_bib182","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.asjsur.2023.11.005","article-title":"Anti-IgLON5 disease with persistent headache: a case report","volume":"47","author":"Sui","year":"2024","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.arr.2024.102639_bib183","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-020-00969-8","article-title":"Phosphorylation and oligomerization of \u03b1-synuclein associated with GSK-3\u03b2 activation in the rTg4510 mouse model of tauopathy","volume":"8","author":"Takaichi","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102639_bib184","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/biomedicines11061646","article-title":"Pick\u2019s disease, seeding an answer to the clinical diagnosis conundrum","volume":"11","author":"Tamvaka","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102639_bib185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/nan.12581","article-title":"Morphological characterisation of glial and neuronal tau pathology in globular glial tauopathy (Types II and III)","volume":"46","author":"Tanaka","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib186","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"14","author":"Tanner","year":"1996","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.arr.2024.102639_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of A liposome-based vaccine against protein tau, assessed in Tau.P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.arr.2024.102639_bib188","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/01.wnl.0000304051.01650.23","article-title":"Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study","volume":"71","author":"Tobin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102639_bib189","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-002-0520-1","article-title":"Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease","volume":"104","author":"Togo","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jnen\/61.6.547","article-title":"Argyrophilic grain disease is a sporadic 4-repeat tauopathy","volume":"61","author":"Togo","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib191","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1440-1789.2004.00591.x","article-title":"Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies","volume":"24","author":"Tolnay","year":"2004","journal-title":"Neuropathol. Off. J. Jpn. Soc. Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib192","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2990.1998.00090.x","article-title":"Argyrophilic grains of Braak: occurrence in dendrites of neurons containing hyperphosphorylated tau protein","volume":"24","author":"Tolnay","year":"1998","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2024.102639_bib193","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(98)00250-X","article-title":"Ballooned neurons expressing alphaB-crystallin as a constant feature of the amygdala in argyrophilic grain disease","volume":"246","author":"Tolnay","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102639_bib194","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00401-002-0591-z","article-title":"Argyrophilic grain disease and Alzheimer\u2019s disease are distinguished by their different distribution of tau protein isoforms","volume":"104","author":"Tolnay","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s004010050642","article-title":"Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons","volume":"93","author":"Tolnay","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102639_bib196","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamaneurol.2019.3812","article-title":"Reactions to multiple ascending doses of the microtubule stabilizer TPI-287 in patients with Alzheimer disease, progressive supranuclear palsy, and corticobasal syndrome: a randomized clinical trial","volume":"77","author":"Tsai","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib197","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.febslet.2014.11.028","article-title":"Intrinsically disordered proteins as crucial constituents of cellular aqueous two phase systems and coacervates","volume":"589","author":"Uversky","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2024.102639_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.624051","article-title":"Antisense oligonucleotide-mediated reduction of HDAC6 does not reduce tau pathology in P301S tau transgenic mice","volume":"12","author":"Valencia","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib199","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.celrep.2016.04.045","article-title":"Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity","volume":"15","author":"Vanderweyde","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102639_bib200","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1523\/JNEUROSCI.1592-12.2012","article-title":"Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies","volume":"32","author":"Vanderweyde","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib201","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/mdc3.12940","article-title":"Open-Label Phase 1 futility studies of salsalate and young plasma in progressive supranuclear palsy","volume":"7","author":"VandeVrede","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.arr.2024.102639_bib202","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1073\/pnas.96.14.8229","article-title":"Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17","volume":"96","author":"Varani","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/alz.039192","article-title":"A phase 1B open-labelled study of sodium selenate as a disease modifying treatment for possible behavioural variant fronto-temporal dementia","volume":"16","author":"Vivash","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102639_bib204","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington\u2019s disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.parkreldis.2015.12.018","article-title":"Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson\u2019s disease","volume":"24","author":"Wang","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2024.102639_bib206","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.120.266122","article-title":"MK-8719, a Novel and Selective O-GlcNAcase inhibitor that reduces the formation of pathological tau and ameliorates neurodegeneration in a mouse model of tauopathy","volume":"374","author":"Wang","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102639_bib208","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2174\/092986606777790566","article-title":"The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains","volume":"13","author":"Wang","year":"2006","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.arr.2024.102639_bib209","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-981-32-9358-8_25","article-title":"Liquid-Liquid Phase Separation of Tau Protein in Neurobiology and Pathology","volume":"1184","author":"Wegmann","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.arr.2024.102639_bib210","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe1611","article-title":"Persistent repression of tau in the brain using engineered zinc finger protein transcription factors","volume":"7","author":"Wegmann","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2024.102639_bib211","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid-liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2024.102639_bib212","first-page":"93","article-title":"Genetics of progressive supranuclear palsy: a review","volume":"11","author":"Wen","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2024.102639_bib213","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib214","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/practneurol-2020-002835","article-title":"Corticobasal syndrome: a practical guide","volume":"21","author":"Wilson","year":"2021","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib215","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","article-title":"The worldwide costs of dementia in 2019","volume":"19","author":"Wimo","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102639_bib216","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-180776","article-title":"Neuronal exosome-derived human tau is toxic to recipient mouse neurons in vivo","volume":"67","author":"Winston","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102639_bib217","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2024.102639_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101409","article-title":"The role of the immune system in Alzheimer\u2019s disease","volume":"70","author":"Wu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102639_bib219","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"\u201cDon\u2019t Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102639_bib220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-021-00795-7","article-title":"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer\u2019s dementia","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102639_bib221","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semcdb.2018.05.005","article-title":"The interaction of \u03b1-synuclein and Tau: a molecular conspiracy in neurodegeneration?","volume":"99","author":"Yan","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2024.102639_bib222","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/1531-8249(200004)47:4<422::AID-ANA4>3.0.CO;2-G","article-title":"A novel mutation at position +\u200912 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)","volume":"47","author":"Yasuda","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102639_bib223","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11910-001-0100-0","article-title":"Frontotemporal dementia and tauopathy","volume":"1","author":"Yoshiyama","year":"2001","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2024.102639_bib224","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1172\/JCI17742","article-title":"Huntingtin in health and disease","volume":"111","author":"Young","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2024.102639_bib225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002183","article-title":"RNA stores tau reversibly in complex coacervates","volume":"15","author":"Zhang","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.arr.2024.102639_bib226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102639_bib227","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41380-022-01446-5","article-title":"Peripheral immunity is associated with the risk of incident dementia","volume":"27","author":"Zhang","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102639_bib228","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0291-3","article-title":"A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model","volume":"13","author":"Zhang","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102639_bib229","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","article-title":"Huntington disease and the huntingtin protein","volume":"107","author":"Zheng","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.arr.2024.102639_bib230","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ng.193","article-title":"Evolutionary toggling of the MAPT 17q21.31 inversion region","volume":"40","author":"Zody","year":"2008","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.arr.2024.102639_bib231","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-180868","article-title":"Tau abnormalities and the potential therapy in Alzheimer\u2019s disease","volume":"67","author":"Almansoub","year":"2019","journal-title":"Journal of Alzheimer's Disease"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T16:58:34Z","timestamp":1738861114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":231,"alternative-id":["S1568163724004574"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102639","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tau in Alzheimer\u2019s and beyond: Insights into pathology and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102639"}}